Sibutramine (cas 106650-56-0), a serotonin–norepinephrine reuptake inhibitor, causes fibrosis in rats

Add time:08/02/2019    Source:sciencedirect.com

Sibutramine hydrochloride monohydrate is a weight loss agent indicated for the treatment of obesity. Although it has been banned from most markets, studies are still relevant as it is often a hidden ingredient in herbal and over the counter slimming products. Sibutramine induces liver fibrosis with steatosis in female Sprague-Dawley rats fed a high-energy diet without significant weight gain. In this study, using the same animal model, the effect of Sibutramine on lung morphology was investigated using histological evaluation of the terminal bronchiole and transmission electron microscopy evaluation of the respiratory tissue. From these results Sibutramine was found to induce lung fibrosis in Sprague-Dawley rats as increased collagen synthesis, mast cell accumulation and aggregates of Bronchus Associated Lymphoid Tissue (BALT) in the terminal bronchiole as well as increased collagen deposition in the respiratory tissue was seen.

We also recommend Trading Suppliers and Manufacturers of Sibutramine (cas 106650-56-0). Pls Click Website Link as below: cas 106650-56-0 suppliers

Prev:A rapid ATR-FTIR spectroscopic method for detection of Sibutramine (cas 106650-56-0) adulteration in tea and coffee based on hierarchical cluster and principal component analyses
Next:Sibutramine (cas 106650-56-0) provokes apoptosis of aortic endothelial cells through altered production of reactive oxygen and nitrogen species)